Report Detail

Technology Global Speech Biomarkers Market Growth (Status and Outlook) 2023-2029

  • RnM4500914
  • |
  • 05 January, 2023
  • |
  • Global
  • |
  • 99 Pages
  • |
  • LPI(LP Information)
  • |
  • Technology

Speech biomarkers are techniques for identifying diseases by the rhythm, frequency, pitch, and breathing of human voices
According to this study, the global Speech Biomarkers market size will reach US$ million by 2029.

Speech biomarkers are the most advantageous objective identification methods for diseases such as psychology, which not only have high recognition rate, but also have the advantages of simple collection, high privacy, and low cost. The screening and monitoring of mental and psychological diseases can be conveniently, objectively and efficiently realized through mobile devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Speech Biomarkers market by product type, application, key players and key regions and countries.

Segmentation by product type:
Frequency
Amplitude
Error Rate
Pronunciation Time

Segmentation by Application:
Mental Disorder
Respiratory Failure
Other

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Boston Technology Corp.
Cogito Corp.
IBM Corp.
conversation HEALTH Group
Winterlight Labs Inc.
Vocalis Health, Inc.
Mayo Clinic Inc.
Medical Information Technology, Inc.
Sonde Health, Inc.
PureTech Health Plc
Orbita Inc.
MediTECH Electronic GmbH
Kintsugi Mindful Wellness
Ellipsis Health
Winter Light Labs
Voice Health Tech


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Speech Biomarkers Market Size 2024-2029
    • 2.1.2 Speech Biomarkers Market Size CAGR by Region
  • 2.2 Speech Biomarkers Segment by Type
    • 2.2.1 Frequency
    • 2.2.2 Amplitude
    • 2.2.3 Error Rate
    • 2.2.4 Pronunciation Time
  • 2.3 Speech Biomarkers Market Size by Type
    • 2.3.1 Global Speech Biomarkers Market Size Market Share by Type (2024-2029)
    • 2.3.2 Global Speech Biomarkers Market Size Growth Rate by Type (2024-2029)
  • 2.4 Speech Biomarkers Segment by Application
    • 2.4.1 Mental Disorder
    • 2.4.2 Respiratory Failure
    • 2.4.3 Other
  • 2.5 Speech Biomarkers Market Size by Application
    • 2.5.1 Global Speech Biomarkers Market Size Market Share by Application (2024-2029)
    • 2.5.2 Global Speech Biomarkers Market Size Growth Rate by Application (2024-2029)

3 Speech Biomarkers Key Players

  • 3.1 Date of Key Players Enter into Speech Biomarkers
  • 3.2 Key Players Speech Biomarkers Product Offered
  • 3.3 Key Players Speech Biomarkers Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Speech Biomarkers Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Speech Biomarkers by Regions

  • 4.1 Speech Biomarkers Market Size by Regions (2024-2029)
  • 4.2 United States Speech Biomarkers Market Size Growth (2024-2029)
  • 4.3 China Speech Biomarkers Market Size Growth (2024-2029)
  • 4.4 Europe Speech Biomarkers Market Size Growth (2024-2029)
  • 4.5 Rest of World Speech Biomarkers Market Size Growth (2024-2029)

5 United States

  • 5.1 United States Speech Biomarkers Market Size by Type (2024-2029)
  • 5.2 United States Speech Biomarkers Market Size by Application (2024-2029)

6 Europe

  • 6.1 Europe Speech Biomarkers Market Size by Type (2024-2029)
  • 6.2 Europe Speech Biomarkers Market Size by Application (2024-2029)

7 China

  • 7.1 China Speech Biomarkers Market Size by Type (2024-2029)
  • 7.2 China Speech Biomarkers Market Size by Application (2024-2029)

8 Rest of World

  • 8.1 Rest of World Speech Biomarkers Market Size by Type (2024-2029)
  • 8.2 Rest of World Speech Biomarkers Market Size by Application (2024-2029)
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Key Investors in Speech Biomarkers

  • 10.1 Company A
    • 10.1.1 Company A Company Details
    • 10.1.2 Company Description
    • 10.1.3 Companies Invested by Company A
    • 10.1.4 Company A Key Development and Market Layout
  • 10.2 Company B
    • 10.2.1 Company B Company Details
    • 10.2.2 Company Description
    • 10.2.3 Companies Invested by Company B
    • 10.2.4 Company B Key Development and Market Layout
  • 10.3 Company C
    • 10.3.1 Company C Company Details
    • 10.3.2 Company Description
    • 10.3.3 Companies Invested by Company C
    • 10.3.4 Company C Key Development and Market Layout
  • 10.4 Company D
  • 10.5 ……

11 Key Players Analysis

  • 11.1 Boston Technology Corp.
    • 11.1.1 Boston Technology Corp. Company Details
    • 11.1.2 Boston Technology Corp. Speech Biomarkers Product Offered
    • 11.1.3 Boston Technology Corp. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.1.4 Boston Technology Corp. Main Business Overview
    • 11.1.5 Boston Technology Corp. News
  • 11.2 Cogito Corp.
    • 11.2.1 Cogito Corp. Company Details
    • 11.2.2 Cogito Corp. Speech Biomarkers Product Offered
    • 11.2.3 Cogito Corp. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.2.4 Cogito Corp. Main Business Overview
    • 11.2.5 Cogito Corp. News
  • 11.3 IBM Corp.
    • 11.3.1 IBM Corp. Company Details
    • 11.3.2 IBM Corp. Speech Biomarkers Product Offered
    • 11.3.3 IBM Corp. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.3.4 IBM Corp. Main Business Overview
    • 11.3.5 IBM Corp. News
  • 11.4 conversation HEALTH Group
    • 11.4.1 conversation HEALTH Group Company Details
    • 11.4.2 conversation HEALTH Group Speech Biomarkers Product Offered
    • 11.4.3 conversation HEALTH Group Speech Biomarkers Market Size (2023 VS 2029)
    • 11.4.4 conversation HEALTH Group Main Business Overview
    • 11.4.5 conversation HEALTH Group News
  • 11.5 Winterlight Labs Inc.
    • 11.5.1 Winterlight Labs Inc. Company Details
    • 11.5.2 Winterlight Labs Inc. Speech Biomarkers Product Offered
    • 11.5.3 Winterlight Labs Inc. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.5.4 Winterlight Labs Inc. Main Business Overview
    • 11.5.5 Winterlight Labs Inc. News
  • 11.6 Vocalis Health, Inc.
    • 11.6.1 Vocalis Health, Inc. Company Details
    • 11.6.2 Vocalis Health, Inc. Speech Biomarkers Product Offered
    • 11.6.3 Vocalis Health, Inc. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.6.4 Vocalis Health, Inc. Main Business Overview
    • 11.6.5 Vocalis Health, Inc. News
  • 11.7 Mayo Clinic Inc.
    • 11.7.1 Mayo Clinic Inc. Company Details
    • 11.7.2 Mayo Clinic Inc. Speech Biomarkers Product Offered
    • 11.7.3 Mayo Clinic Inc. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.7.4 Mayo Clinic Inc. Main Business Overview
    • 11.7.5 Mayo Clinic Inc. News
  • 11.8 Medical Information Technology, Inc.
    • 11.8.1 Medical Information Technology, Inc. Company Details
    • 11.8.2 Medical Information Technology, Inc. Speech Biomarkers Product Offered
    • 11.8.3 Medical Information Technology, Inc. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.8.4 Medical Information Technology, Inc. Main Business Overview
    • 11.8.5 Medical Information Technology, Inc. News
  • 11.9 Sonde Health, Inc.
    • 11.9.1 Sonde Health, Inc. Company Details
    • 11.9.2 Sonde Health, Inc. Speech Biomarkers Product Offered
    • 11.9.3 Sonde Health, Inc. Speech Biomarkers Market Size (2023 VS 2029)
    • 11.9.4 Sonde Health, Inc. Main Business Overview
    • 11.9.5 Sonde Health, Inc. News
  • 11.10 PureTech Health Plc
    • 11.10.1 PureTech Health Plc Company Details
    • 11.10.2 PureTech Health Plc Speech Biomarkers Product Offered
    • 11.10.3 PureTech Health Plc Speech Biomarkers Market Size (2023 VS 2029)
    • 11.10.4 PureTech Health Plc Main Business Overview
    • 11.10.5 PureTech Health Plc News
  • 11.11 Orbita Inc.
  • 11.12 MediTECH Electronic GmbH
  • 11.13 Kintsugi Mindful Wellness
  • 11.14 Ellipsis Health
  • 11.15 Winter Light Labs
  • 11.16 Voice Health Tech

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Speech Biomarkers . Industry analysis & Market Report on Speech Biomarkers is a syndicated market report, published as Global Speech Biomarkers Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Speech Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,986.56
5,973.12
3,348.90
6,697.80
470,639.40
941,278.80
300,522.60
601,045.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report